TerminatedPHASE1, PHASE2NCT01840046

Evaluation of the Efficacy and Tolerability of Treatment With Interleukin-2 in Severe and Resistant Alopecia Areata

Studying Alopecia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Centre Hospitalier Universitaire de Nice
Principal Investigator
PASSERON Thierry, PhD
CHU de Nice - Hôpital de l'Archet - Dermatology
Intervention
Interleukin-2(drug)
Enrollment
4 target
Eligibility
18-60 years · All sexes
Timeline
20122013

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01840046 on ClinicalTrials.gov

Other trials for Alopecia

Additional recruiting or active studies for the same condition.

See all trials for Alopecia

← Back to all trials